Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 255

2.

Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension.

Lin L, Zhao YJ, Chew PT, Sng CC, Wong HT, Yip LW, Wu TS, Bautista D, Teng M, Khoo AL, Lim BP.

Ann Pharmacother. 2014 Dec;48(12):1585-93. doi: 10.1177/1060028014548569.

PMID:
25184309
3.

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, Davis AA; Travoprost Study Group..

Am J Ophthalmol. 2001 Oct;132(4):472-84.

PMID:
11589866
4.

Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs.

Eisenberg DL, Toris CB, Camras CB.

Surv Ophthalmol. 2002 Aug;47 Suppl 1:S105-15. Review.

PMID:
12204706
5.

Conjunctival hyperaemia with the use of latanoprost versus other prostaglandin analogues in patients with ocular hypertension or glaucoma: a meta-analysis of randomised clinical trials.

Honrubia F, García-Sánchez J, Polo V, de la Casa JM, Soto J.

Br J Ophthalmol. 2009 Mar;93(3):316-21. doi: 10.1136/bjo.2007.135111. Review.

6.

Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.

Easthope SE, Perry CM.

Drugs Aging. 2002;19(3):231-48. Review.

PMID:
12027782
8.

Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.

Rossetti L, Karabatsas CH, Topouzis F, Vetrugno M, Centofanti M, Boehm A, Viswanathan A, Vorwerk C, Goldblum D.

Ophthalmology. 2007 Dec;114(12):2244-51.

PMID:
17459480
9.

Prostaglandin analog treatment of glaucoma and ocular hypertension.

Alexander CL, Miller SJ, Abel SR.

Ann Pharmacother. 2002 Mar;36(3):504-11. Review.

PMID:
11895065
10.

Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma.

Holmstrom S, Buchholz P, Walt J, Wickstrøm J, Aagren M.

Curr Med Res Opin. 2005 Nov;21(11):1875-83. Review.

PMID:
16307709
11.
12.

Latanoprost : an update of its use in glaucoma and ocular hypertension.

Perry CM, McGavin JK, Culy CR, Ibbotson T.

Drugs Aging. 2003;20(8):597-630. Review.

PMID:
12795627
13.
14.

Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial.

Arcieri ES, Santana A, Rocha FN, Guapo GL, Costa VP.

Arch Ophthalmol. 2005 Feb;123(2):186-92.

PMID:
15710814
15.

Efficacy and tolerability of bimatoprost versus travoprost in patients previously on latanoprost: a 3-month, randomised, masked-evaluator, multicentre study.

Kammer JA, Katzman B, Ackerman SL, Hollander DA.

Br J Ophthalmol. 2010 Jan;94(1):74-9. doi: 10.1136/bjo.2009.158071.

16.
17.

A comparison of bimatoprost 0.03% versus the fixed-combination of latanoprost 0.005% and timolol 0.5% in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label trial.

Facio AC, Reis AS, Vidal KS, de Moraes CG, Suzuki R, Hatanaka M, Susanna R.

J Ocul Pharmacol Ther. 2009 Oct;25(5):447-51. doi: 10.1089/jop.2009.0018.

PMID:
19860553
18.

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

Camras CB.

Am J Ophthalmol. 2002 May;133(5):732; author reply 732-3. No abstract available.

PMID:
11992888
19.

Efficacy and tolerability of prostaglandin analogs: a meta-analysis of randomized controlled clinical trials.

Aptel F, Cucherat M, Denis P.

J Glaucoma. 2008 Dec;17(8):667-73. doi: 10.1097/IJG.0b013e3181666557.

PMID:
19092464
20.

Comparative study of three prostaglandin analogues in the treatment of newly diagnosed cases of ocular hypertension, open-angle and normal tension glaucoma.

Faridi UA, Saleh TA, Ewings P, Venkateswaran M, Cadman DH, Samarasinghe RA, Vodden J, Claridge KG.

Clin Exp Ophthalmol. 2010 Oct;38(7):678-82. doi: 10.1111/j.1442-9071.2010.02305.x.

PMID:
20456437

Supplemental Content

Support Center